Related Experiment Videos
Renal function following liver transplantation in children
1Department of Pediatrics, Stony Brook University, Stony Brook, NY 11794-8111, USA. richard.fine@stonybrook.edu
Pediatric Transplantation
|September 24, 2005
Summary
Pediatric liver transplant patients may experience kidney problems, often linked to cyclosporine. Minimizing calcineurin inhibitors can help protect kidney function, but more research is needed.
Area of Science:
- Pediatric Nephrology
- Transplantation Immunology
- Clinical Pharmacology
Background:
- Renal functional impairment is a concern in pediatric liver allograft recipients.
- Cyclosporine is frequently used as the primary immunosuppressant in these patients.
- Current methods like calculated glomerular filtration rate (cGFR) may overestimate actual kidney function.
Purpose of the Study:
- To review the etiology and incidence of renal functional impairment in pediatric liver allograft recipients.
- To evaluate the impact of immunosuppression on kidney function in this population.
- To identify gaps in knowledge regarding long-term renal outcomes.
Main Methods:
- Literature review of studies on pediatric liver allograft recipients.
- Analysis of reported causes and frequency of renal dysfunction.
- Examination of the role of specific immunosuppressants, particularly cyclosporine.
Main Results:
- Limited data exist on pediatric recipients progressing to chronic kidney disease or end-stage renal disease.
- Calcineurin inhibitor minimization shows potential in preserving or improving glomerular filtration rate (GFR).
- Rejection episodes and associated complications can hinder the effectiveness of immunosuppression minimization strategies.
Conclusions:
- Pediatric liver transplant recipients face risks of renal functional impairment.
- Strategies to minimize calcineurin inhibitors may be beneficial but have limitations.
- Further multicenter research employing accurate GFR measurements is essential to fully understand renal dysfunction in these patients.